Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Interim CFO | August 17, 2026 | August 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date August 17, 2026 · Filed August 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,249,526 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Sale · Disposed 17,775 · Balance 1,249,526 F1: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on August 16, 2026. The RSUs were originally granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on August 16, 2026. The RSUs were originally granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 17, 2026 21:58 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 17,775 | $4.39 | $78,032.25 |
DisclosureSEC source: 0001801170-26-000207 · wk-form4_1787003898.xml · nonDerivative · entry 1 THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,249,526 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on August 16, 2026. The RSUs were originally granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 20:20 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 54,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-26-000202 · wk-form4_1786652455.xml · nonDerivative · entry 1 THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,267,301 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of August 12, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 12, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on August 12, 2030. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:42 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 4,630 | $4.67 | $21,622.10 |
DisclosureSEC source: 0001801170-26-000174 · wk-form4_1784234535.xml · nonDerivative · entry 1 THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,212,954 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 16, 2026 Filed May 18, 2026 20:23 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 16,942 | $3.47 | $58,788.74 |
DisclosureSEC source: 0001801170-26-000130 · wk-form4_1779135782.xml · nonDerivative · entry 1 THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,217,584 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on May 16, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 20:12 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 4,158 | $2.04 | $8,482.32 |
DisclosureSEC source: 0001801170-26-000089 · wk-form4_1776370321.xml · nonDerivative · entry 1 THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,234,526 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.